Article
UPDATED: Merck pulls the plug on a study evaluating blockbuster Keytruda with Yervoy for NSCLC
Rating:
0.0
Views:
130
Likes:
1
Library:
1
About a month ago, upon touting new oncology data, Merck reaffirmed its commitment to exploring new Keytruda combinations for lung cancer patients. The Big Pharma has now pulled the plug on one of those combinations, after interim data showed an increased risk and no reward. An independent Data Monitoring Committee
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value